Literature DB >> 178831

A comparison of the fine structure of motor end-plates in Duchenne dystrophy and in human neurogenic diseases.

D G Harriman.   

Abstract

With the aim of investigating the pathogenesis of Duchenne dystrophy, and in particular the role of denervation, the fine structural features of motor end-plates in the limb muscles of 13 patients with Duchenne dystrophy were compared with those in 26 controls and 50 patients suffering from known neurogenic diseases. The wide variation in control end-plates es emphasised. The sole plates in Duchenne dystrophy tended to retract from the end-plate, and shared only sprout formation, enclodure of terminals in Schwann cell cytoplasm and (in one instance) close packing of neurofilaments in the terminal with the changes in denervating end-plates. In these latter, withdrawal of terminals from the sole and various degenerative figures were the rule. It was concluded that there is no adequate morphological evidence in motor end-plates to support the concept of Duchenne dystrophy as a neurogenic disease.

Entities:  

Mesh:

Year:  1976        PMID: 178831     DOI: 10.1016/0022-510x(76)90106-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  An unusual cytoplasmic organelle of the perineurium in a case of Duchenne muscular dystrophy.

Authors:  R Schober
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

2.  Ultrastructural studies on the neuromuscular junctions of Becker's muscular dystrophy.

Authors:  N Fukuhara; M Suzuki; T Tsubaki; S Kushiro; N Takasawa
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

3.  Ultrastructural changes of skeletal muscles in polyarteritis nodosa and in arteritis assoicated with rheumatoid arthritis.

Authors:  S Matsubara; W G Mair
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

Review 4.  Recent insights into neuromuscular junction biology in Duchenne muscular dystrophy: Impacts, challenges, and opportunities.

Authors:  Sean Y Ng; Vladimir Ljubicic
Journal:  EBioMedicine       Date:  2020-10-08       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.